GRAIL is a healthcare company whose mission is to detect cancer early when it can be cured and is focused on saving lives and improving health by pioneering new technologies for early cancer detection. Their first product, the Galleri® multi-cancer early detection test, complements guideline-recommended screenings, and can detect a cancer signal across more than 50 types of cancer through a routine blood draw for adults with elevated risk, such as aged 50 or older. For more information visit Booth #551 or Galleri.com.
GRAIL has the mission to detect cancer early when it can be cured. The Galleri® test screens for multiple cancers through a simple blood draw. When a shared signal is detected, it can predict the cancer signal origin. For important safety information visit Booth #1326 or Galleri.com.